Insight

Breakthrough in cancer cachexia with Ponsegromab treatment

Photo taken from John Groarke/LinkedIn

Sep 23, 2024, 13:34

Breakthrough in cancer cachexia with Ponsegromab treatment

Hagen Kennecke, Chief health officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared a post by NEJM, on X:

“Possible breakthrough in cancer cachexia with Ponsegromab, anti-GDF 15.

Significant weight gain, especially in patients with colorectal cancer.”

Quoting NEJM’s post:

“Ponsegromab for the Treatment of Cancer Cachexia.

Authors: John D. Groarke, Jeffrey Crawford, Susie M. Collins, Shannon Lubaczewski,Eric J. Roeland, Tateaki Naito, Andrew E. Hendifar,Marie Fallon, Koichi Takayama, Timothy Asmis, Richard F. Dunne,Isik Karahanoglu, Carrie A. Northcott, Magdalena A. Harrington, Michelle Rossulek, Ruolun Qiu , Aditi R. Saxena.“

Breakthrough in cancer cachexia with Ponsegromab treatment

Source: Hagen Kennecke/X and NEJM/X

Aditi R. Saxena Andrew E. Hendifar anti- GDF15 cachexia cancer Carrie A. Northcott colorectal cancer Eric J. Roeland Hagen Kennecke Isik Karahanoglu Jeffrey Crawford John D. Groarke Koichi Takayama Magdalena A. Harrington Marie Fallon Michelle Rossulek NEJM OncoDaily Oncology Ponsegromab Richard F. Dunne Ruolun Qiu Shannon Lubaczewski Susie M. Collins Tateaki Naito Timothy Asmis

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers